Gold, H. T., Hall, M. J., Blinder, V., & Schackman, B. R. (2009). Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer.
Citação norma ChicagoGold, Heather T., Michael J. Hall, Victoria Blinder, and Bruce R. Schackman. Cost Effectiveness of Pharmacogenetic Testing for UGT1A1 Before Irinotecan Administration for Metastatic Colorectal Cancer. 2009.
MLA citiranjeGold, Heather T., Michael J. Hall, Victoria Blinder, and Bruce R. Schackman. Cost Effectiveness of Pharmacogenetic Testing for UGT1A1 Before Irinotecan Administration for Metastatic Colorectal Cancer. 2009.
Opozorilo: Ti citati niso vedno 100% točni.